Page 1 | Search Results | Hematology, ASH Education Program

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Myeloma: next generation immunotherapy

Adam D. Cohen

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 266–272.

https://doi.org/10.1182/hematology.2019000068

Published: 2019

Journal Articles

Clonal evolution and immune evasion in posttransplantation relapses

Luca Vago

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 610–616.

https://doi.org/10.1182/hematology.2019000005

Published: 2019

Journal Articles

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Stephen M. Ansell

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 618–621.

https://doi.org/10.1182/asheducation-2017.1.618

Published: 2017

Journal Articles

Checkpoint inhibition and cellular immunotherapy in lymphoma

Premal Lulla, Helen E. Heslop

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 390–396.

https://doi.org/10.1182/asheducation-2016.1.390

Published: 2016

Journal Articles

Checkpoint inhibition in myeloma

Don M. Benson, Jr

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 528–533.

https://doi.org/10.1182/asheducation-2016.1.528

Published: 2016

Journal Articles

Checkpoint blockade in lymphoma

Philippe Armand

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 69–73.

https://doi.org/10.1182/asheducation-2015.1.69

Published: 2015

Journal Articles

The Molecular Pathology of Acute Myeloid Leukemia

Jonathan D. Licht, David W. Sternberg

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 137–142.

https://doi.org/10.1182/asheducation-2005.1.137

Published: 2005

Journal Articles

New Developments in the Therapy of Acute Myelocytic Leukemia

Norbert C. Gorin, Elihu Estey, Richard J. Jones, Hyam I. Levitsky, Ivan Borrello, Shimon Slavin

Hematology Am Soc Hematol Educ Program (2000) 2000 (1): 69–89.

https://doi.org/10.1182/asheducation.V2000.1.69.69

Published: 2000

NARROW

Myeloma: next generation immunotherapy

Clonal evolution and immune evasion in posttransplantation relapses

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Checkpoint inhibition and cellular immunotherapy in lymphoma

Checkpoint inhibition in myeloma

Checkpoint blockade in lymphoma

The Molecular Pathology of Acute Myeloid Leukemia

New Developments in the Therapy of Acute Myelocytic Leukemia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only